Molly Weaver, PhD

As Chief Operating Officer, Dr. Weaver is responsible for Apiject’s development of Blow-Fill-Seal injection devices and production of its initial device, a single-dose prefilled drug delivery system. She leads a dynamic team that aims for innovation in new design and continuous improvement on existing ones.

Dr. Weaver is a seasoned industry leader whose leadership and expertise spans strategy, product development, and execution across a broad range of drug delivery systems. This relevant experience has been applied in developing injectable technologies comprising self-injection devices and other injectable platforms, as well as to manage and launch products and commercialization of devices globally, including European and Asian markets.

She most recently served as Vice President for Containment Systems & Portfolio Management at West Pharmaceutical Services where she was responsible for elastomer and container R&D, product packaging and sterilization, and management of more than 30 projects across the full West portfolio of work, including partnership with commercial fill-finish operations. She previously worked at Becton Dickinson & Company and Unilife Medical Corporation. Dr. Weaver holds a Ph.D. in Mechanical Engineering Materials Science from Duke University, an ScB from Brown University, and has published research in top journals in her field.